Suchergebnisse für “Vce SY0-701 Exam 💫 Exam SY0-701 Lab Questions 🍅 SY0-701 Latest Exam Fee 🙆 Search for ➠ SY0-701 🠰 on ▛ www.pdfvce.com ▟ immediately to obtain a free download 🙀Authorized SY0-701 Test Dumps”

Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men with Biochemical Recurrence of Prostate Cancer

Solar-Stage: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection

Nuclear medicine education

Welcome customers Thank you for visiting our Nuclear Medicine Education website. Through this website we strive to provide a robust variety of Continuing Education (CE) programs relevant to the Nuclear Medicine Technologist. All courses are structured in a self-paced learning format, conveniently accessible 24 hours a day, 7 days a week, and include course assessments […]

Überblick

RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.

Ressourcen

Curium U.S. invoice terms and conditions of sale

Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.

Europäische Produkte

Sodium Iodide I-123 Capsules

Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.

Startseite

Ioflupane I 123 Injection

Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration

RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA

36th Annual Congress of the European Association of Nuclear Medicine

From March 23-25, we will be attending the 9th edition of Journées Francophones de Médecine Nucléaire (JFMN) at the Belfri de Montrouge, in the Paris region, France. Meet Curium team at booth 45B and attend our symposium presentation to gain insights into our multiomic approach to patient care. Symposium Presentation Speakers: PR.PY. SALAÜN, Dépistage de […]

Überblick

APhA Annual Meeting & Exposition

From March 23-25, we will be attending the 9th edition of Journées Francophones de Médecine Nucléaire (JFMN) at the Belfri de Montrouge, in the Paris region, France. Meet Curium team at booth 45B and attend our symposium presentation to gain insights into our multiomic approach to patient care. Symposium Presentation Speakers: PR.PY. SALAÜN, Dépistage de […]

Überblick

Über Curium

Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas

Ultratag™ RBC

Ultratag™ RBC

Curium und RadioMedix geben eine exklusive Vereinbarung für die 64Cu-Dotatate-Entwicklung bekannt.

Ultra-Technekow™ V4

Ultra-Technekow™ V4

Technescan™ HDP

Detectnet™

NRG and Curium Sign Multi-Year Isotope Production Contract

30 Years in NETs

RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application

Curium to Expand Noblesville Facility’s Workforce

Curium Acquires Austrian Radiopharmaceuticals Company IASON

Curium Announces The Submission Of Its Marketing Authorization Application For [18F]-DCFPyL To The European Medicines Agency

Xenotron™ I

Kooperation von Curium und ROTOP zur Versorgung von Patienten mit STRIASCANTM

Curium confirms no supply challenges in North America and Europe for its ECLIPSE Phase 3 clinical trial

Curium announces last patient enrolled in their Phase 1/2 SOLAR clinical trial imaging men with histologically-proven metastatic prostate cancer using copper Cu 64 PSMA I&T

Curium und PIUR IMAGING kündigen eine Partnerschaft für die Schilddrüsenbildgebung in Deutschland an, um tomographische 3D-Ultraschallösungen zu ermöglichen

Pulmotech™ MAA

Curium: erste kommerzielle dosen von PYLCLARI® in Deutschland verfügbar – ein innovativer 18F-PSMA PET tracer für patienten mit prostatakrebs

Curium Gibt Erste Kommerzielle Dosen von Pylclari® – ¹⁸F-PSMA PET Radiopharmazeutikum in Österreich Bekannt

Octreoscan™

Kit for the Preparation of Technetium Tc 99m Sestamibi Injection

Technescan MAG3™

Gallium Citrate Ga 67 Injection

Technescan™ PYP™

Technescan MAG3™

Thallous Chloride Tl 201 Injection

Kit for the Preparation of Technetium Tc99m Sestamibi Injection

Xenon Xe 133 Gas

Octreoscan™

Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations

Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy

Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)

Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio

Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe

Online Ordering (Dublin, Ireland)

Curium to become major player in the supply on non carrier added Lu-177

Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients

Investigator Initiated Studies

Curium’s Customers to benefit from Mo-99 Production restart

Curium’s 14 million patients to benefit from regular supply of Mo-99 and TC-99